Shares of Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) traded today at $65.35, eclipsing its 52-week high. So far today approximately 713,000 shares have been exchanged, as compared to an average 30-day volume of 613,000 shares.
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) defies analysts with a current price ($63.99) 23.2% above its average consensus price target of $49.14.
Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency and RP-L4011 for Infantile Malignant Osteopetrosis.
Rocket Pharmaceuticals Inc. share prices have moved between a 52-week high of $65.35 and a 52-week low of $9.01 and are now trading 610% above that low price at $63.99 per share.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer